scholarly journals Correction: Roncoroni, L. et al. A Low FODMAP Gluten-Free Diet Improves Functional Gastrointestinal Disorders and Overall Mental Health of Celiac Disease Patients: A Randomized Controlled Trial. Nutrients 2018, 10, 1023

Nutrients ◽  
2019 ◽  
Vol 11 (3) ◽  
pp. 566 ◽  
Author(s):  
Leda Roncoroni ◽  
Karla Bascuñán ◽  
Luisa Doneda ◽  
Alice Scricciolo ◽  
Vincenza Lombardo ◽  
...  
Keyword(s):  
Mental Health ◽  
Randomized Controlled Trial ◽  
Celiac Disease ◽  
Controlled Trial ◽  
Functional Gastrointestinal Disorders ◽  
Gluten Free Diet ◽  
Gastrointestinal Disorders ◽  
Gluten Free ◽  
Randomized Controlled

The authors have requested that the following changes be made to their paper [...]

scholarly journals Effects of 12 Weeks of Strength Training and Gluten-Free Diet on Quality of Life, Body Composition and Strength in Women with Celiac Disease: A Randomized Controlled Trial

2021 ◽  
Vol 11 (22) ◽  
pp. 10960
Author(s):  
Alejandro Martínez-Rodríguez ◽  
Daniela Alejandra Loaiza-Martínez ◽  
Javier Sánchez-Sánchez ◽  
Jacobo A. Rubio-Arias ◽  
Fernando Alacid ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Randomized Controlled Trial ◽  
Body Composition ◽  
Celiac Disease ◽  
Controlled Trial ◽  
Gluten Free Diet ◽  
Gluten Free ◽  
Randomized Controlled ◽  
Group 1

Celiac disease (CD) is an autoimmune disease characterized by gluten-induced intestinal inflammation. Dietary restrictions and symptoms may have a significant impact on the patient’s quality of life, body composition (BC), and strength. This study was designed to assess the impact of an isocaloric gluten free diet and resistance exercise in women. A total of 28 Spanish women, aged 40 years old or more, took part in a randomized controlled trial. Each group received a different intervention: group 1, gluten-free nutrition plan + exercise (GFD + E); group 2, gluten-free nutrition plan (GFD); group 3, celiac controls (NO-GFD); and group 4, non-celiac controls (CONTROL). The variables studied were quality of life, BC and isometric hand strength. After 12 weeks of intervention, celiac women that followed a gluten-free diet and exercise showed higher scores on the psychological health scale than celiac women without intervention. The women in group 1 were the only ones who presented improvements in BC variables; fat mass, BMI, and fat-free mass. Negative correlations were found between the perception of quality of life and age, however a positive correlation between quality of life and isometric strength test results was found. In addition to a gluten-free diet, resistance training is essential to improve BC, strength, and gastrointestinal symptoms.

EFFECT OF GLUTEN-FREE DIET ON METABOLIC CONTROL AND ANTHROPOMETRIC PARAMETERS IN TYPE 1 DIABETES WITH SUBCLINICAL CELIAC DISEASE: A RANDOMIZED CONTROLLED TRIAL

2020 ◽  
Vol 26 (6) ◽  
pp. 660-667 ◽  
Author(s):  
Parjeet Kaur ◽  
Anuja Agarwala ◽  
Govind Makharia ◽  
Shinjini Bhatnagar ◽  
Nikhil Tandon
Keyword(s):  
Randomized Controlled Trial ◽  
Type 1 Diabetes ◽  
Celiac Disease ◽  
Blood Glucose ◽  
Controlled Trial ◽  
Gluten Free Diet ◽  
Gluten Free ◽  
Randomized Controlled ◽  
The Mean

Objective: It is unclear whether the institution of gluten-free diet (GFD) is beneficial in patients with type 1 diabetes (T1DM) and subclinical celiac disease (CD). Our primary objective was to evaluate the effect of GFD on the frequency of hypoglycemia, in patients with T1DM and subclinical CD. Our secondary objective was to investigate the effect of GFD on height, weight, glycosylated hemoglobin (HbA1c), insulin dose requirement, and bone mineral homeostasis. Methods: We carried out a prospective open label randomized controlled trial (RCT). Patients with T1DM and subclinical CD were randomized to receive GFD or a normal diet for 1 year. The primary outcome was the frequency of hypoglycemic episodes (blood glucose <70 mg/dL) measured by self-monitoring of blood glucose (SMBG) at the sixth month of the study in the 2 groups. Results: Screening for CD was carried out in 320 T1DM patients. Thirty eligible patients were randomized to receive GFD (n = 15) or a normal diet (n = 15). The mean number of hypoglycemic episodes/month recorded by SMBG and the mean time spent in hypoglycemia measured by CGM (minutes) in the GFD group versus the non-GFD group at six months was 2.3 minutes versus 3.4 minutes ( P = .5) and 124.1 minutes versus 356.9 minutes ( P = .1), respectively. The mean number of hypoglycemic episodes/month significantly declined in the GFD group (3.5 episodes at baseline versus 2.3 episodes at the sixth month; P = .03). The mean HbA1c declined by 0.73% in the GFD group and rose by 0.99% in non-GFD group at study completion. Conclusion: This is the first RCT to assess the effect of GFD in T1DM and subclinical CD. A trend towards a decrease in hypoglycemic episodes and better glycemic control was seen in patients receiving GFD. Abbreviations: BMC = bone mineral content; BMI = body mass index; CD = celiac disease; CGM = continuous glucose monitoring; GFD = gluten-free diet; Hb = hemoglobin; HbA1c = glycosylated hemoglobin; iPTH = intact parathyroid hormone; RCT = randomized controlled trial; SMBG = self-monitoring of blood glucose; T1DM = type 1 diabetes mellitus; tTG-IgA = tissue transglutaminase immunoglobulin A

scholarly journals Larazotide Acetate for Persistent Symptoms of Celiac Disease Despite a Gluten-Free Diet: A Randomized Controlled Trial

2015 ◽  
Vol 148 (7) ◽  
pp. 1311-1319.e6 ◽  
Author(s):  
Daniel A. Leffler ◽  
Ciaran P. Kelly ◽  
Peter H.R. Green ◽  
Richard N. Fedorak ◽  
Anthony DiMarino ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Celiac Disease ◽  
Controlled Trial ◽  
Gluten Free Diet ◽  
Gluten Free ◽  
Persistent Symptoms ◽  
Randomized Controlled
Sign in / Sign up

Export Citation Format

Share Document